121 related articles for article (PubMed ID: 16760301)
1. Molecular detection of TP53, Ki-Ras and p16INK4A promoter methylation in plasma of patients with colorectal cancer and its association with prognosis. Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study.
Bazan V; Bruno L; Augello C; Agnese V; Calò V; Corsale S; Gargano G; Terrasi M; Schirò V; Di Fede G; Adamo V; Intrivici C; Crosta A; Rinaldi G; Latteri F; Dardanoni G; Grassi N; Valerio MR; Colucci G; Macaluso M; Russo A;
Ann Oncol; 2006 Jun; 17 Suppl 7():vii84-90. PubMed ID: 16760301
[TBL] [Abstract][Full Text] [Related]
2. Specific TP53 and/or Ki-ras mutations as independent predictors of clinical outcome in sporadic colorectal adenocarcinomas: results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study.
Bazan V; Agnese V; Corsale S; Calò V; Valerio MR; Latteri MA; Vieni S; Grassi N; Cicero G; Dardanoni G; Tomasino RM; Colucci G; Gebbia N; Russo A;
Ann Oncol; 2005 May; 16 Suppl 4():iv50-55. PubMed ID: 15923430
[TBL] [Abstract][Full Text] [Related]
3. Significance of P16INK4A hypermethylation gene in primary head/neck and colorectal tumors: it is a specific tissue event? Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study.
Agnese V; Corsale S; Calò V; Augello C; Bruno L; Calcara D; Crosta A; Rodolico V; Rinaldi G; Cicero G; Latteri F; Agrusa A; Morello V; Adamo V; Altavilla G; Di Fede G; Fiorentino E; Grassi N; Latteri MA; Valerio MR; Tomasino RM; Colucci G; Bazan V; Russo A;
Ann Oncol; 2006 Jun; 17 Suppl 7():vii137-41. PubMed ID: 16760277
[TBL] [Abstract][Full Text] [Related]
4. DNA aneuploidy and high proliferative activity but not K-ras-2 mutations as independent predictors of clinical outcome in operable gastric carcinoma: results of a 5-year Gruppo Oncologico dell'Italia Meridonale (GDIM) prospective study.
Russo A; Bazan V; Migliavacca M; Tubiolo C; Macaluso M; Zanna I; Corsale S; Latteri F; Valerio MR; Pantuso G; Morello V; Dardanoni G; Latteri MA; Colucci G; Tomasino RM; Gebbia N
Cancer; 2001 Jul; 92(2):294-302. PubMed ID: 11466682
[TBL] [Abstract][Full Text] [Related]
5. p53 and Ki-ras as prognostic factors for Dukes' stage B colorectal cancer.
Bouzourene H; Gervaz P; Cerottini JP; Benhattar J; Chaubert P; Saraga E; Pampallona S; Bosman FT; Givel JC
Eur J Cancer; 2000 May; 36(8):1008-15. PubMed ID: 10885605
[TBL] [Abstract][Full Text] [Related]
6. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
7. Molecular detection of APC, K- ras, and p53 mutations in the serum of colorectal cancer patients as circulating biomarkers.
Wang JY; Hsieh JS; Chang MY; Huang TJ; Chen FM; Cheng TL; Alexandersen K; Huang YS; Tzou WS; Lin SR
World J Surg; 2004 Jul; 28(7):721-6. PubMed ID: 15185002
[TBL] [Abstract][Full Text] [Related]
8. Comethylation of p16 and MGMT genes in colorectal carcinoma: correlation with clinicopathological features and prognostic value.
Krtolica K; Krajnovic M; Usaj-Knezevic S; Babic D; Jovanovic D; Dimitrijevic B
World J Gastroenterol; 2007 Feb; 13(8):1187-94. PubMed ID: 17451198
[TBL] [Abstract][Full Text] [Related]
9. K-ras and p16 aberrations confer poor prognosis in human colorectal cancer.
Esteller M; González S; Risques RA; Marcuello E; Mangues R; Germà JR; Herman JG; Capellà G; Peinado MA
J Clin Oncol; 2001 Jan; 19(2):299-304. PubMed ID: 11208819
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of p16INK4a by CpG hypermethylation is not a frequent event in colorectal cancer.
Norrie MW; Hawkins NJ; Todd AV; Meagher AP; O'Connor TW; Ward RL
J Surg Oncol; 2003 Nov; 84(3):143-50. PubMed ID: 14598358
[TBL] [Abstract][Full Text] [Related]
11. Somatic mutations, acetylator status, and prognosis in colorectal cancer.
Hardingham JE; Butler WJ; Roder D; Dobrovic A; Dymock RB; Sage RE; Roberts-Thomson IC
Gut; 1998 May; 42(5):669-72. PubMed ID: 9659162
[TBL] [Abstract][Full Text] [Related]
12. Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis.
Lecomte T; Berger A; Zinzindohoué F; Micard S; Landi B; Blons H; Beaune P; Cugnenc PH; Laurent-Puig P
Int J Cancer; 2002 Aug; 100(5):542-8. PubMed ID: 12124803
[TBL] [Abstract][Full Text] [Related]
13. p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer.
Bearzatto A; Conte D; Frattini M; Zaffaroni N; Andriani F; Balestra D; Tavecchio L; Daidone MG; Sozzi G
Clin Cancer Res; 2002 Dec; 8(12):3782-7. PubMed ID: 12473590
[TBL] [Abstract][Full Text] [Related]
14. TP53, p14ARF, p16INK4a and H-ras gene molecular analysis in intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses.
Perrone F; Oggionni M; Birindelli S; Suardi S; Tabano S; Romano R; Moiraghi ML; Bimbi G; Quattrone P; Cantu G; Pierotti MA; Licitra L; Pilotti S
Int J Cancer; 2003 Jun; 105(2):196-203. PubMed ID: 12673679
[TBL] [Abstract][Full Text] [Related]
15. Mutations in the p53 and Ki-ras genes, microsatellite instability and site of tumor origin in colorectal cancer.
Catalano T; Curia MC; Aceto G; Verginelli F; Cascinu S; Cama A; Mariani-Costantini R; Teti D; Battista P
Oncol Rep; 2005 Sep; 14(3):625-31. PubMed ID: 16077965
[TBL] [Abstract][Full Text] [Related]
16. Differential frequencies of p16(INK4a) promoter hypermethylation, p53 mutation, and K-ras mutation in exfoliative material mark the development of lung cancer in symptomatic chronic smokers.
Kersting M; Friedl C; Kraus A; Behn M; Pankow W; Schuermann M
J Clin Oncol; 2000 Sep; 18(18):3221-9. PubMed ID: 10986054
[TBL] [Abstract][Full Text] [Related]
17. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
[TBL] [Abstract][Full Text] [Related]
18. Detection of tumor cells in blood using CD45 magnetic cell separation followed by nested mutant allele-specific amplification of p53 and K-ras genes in patients with colorectal cancer.
Iinuma H; Okinaga K; Adachi M; Suda K; Sekine T; Sakagawa K; Baba Y; Tamura J; Kumagai H; Ida A
Int J Cancer; 2000 Jul; 89(4):337-44. PubMed ID: 10956407
[TBL] [Abstract][Full Text] [Related]
19. p14ARF promoter hypermethylation in plasma DNA as an indicator of disease recurrence in bladder cancer patients.
Domínguez G; Carballido J; Silva J; Silva JM; García JM; Menéndez J; Provencio M; España P; Bonilla F
Clin Cancer Res; 2002 Apr; 8(4):980-5. PubMed ID: 11948103
[TBL] [Abstract][Full Text] [Related]
20. Hypermethylation of the p16 gene in sporadic T3N0M0 stage colorectal cancers: association with DNA replication error and shorter survival.
Liang JT; Chang KJ; Chen JC; Lee CC; Cheng YM; Hsu HC; Wu MS; Wang SM; Lin JT; Cheng AL
Oncology; 1999; 57(2):149-56. PubMed ID: 10461063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
